Bayesian Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-34,100
| Closed | -$554K | – | 1033 |
|
|
2024
Q2 | $554K | Buy |
+34,100
| New | +$554K | 0.06% | 344 |
|
|
2023
Q2 | – | Sell |
-39,300
| Closed | -$348K | – | 1061 |
|
|
2023
Q1 | $348K | Buy |
+39,300
| New | +$348K | 0.04% | 474 |
|
|
2022
Q3 | – | Sell |
-36,900
| Closed | -$277K | – | 1012 |
|
|
2022
Q2 | $277K | Sell |
36,900
-41,600
| -53% | -$312K | 0.05% | 507 |
|
|
2022
Q1 | $737K | Buy |
+78,500
| New | +$737K | 0.11% | 274 |
|
|
2021
Q2 | – | Sell |
-31,700
| Closed | -$366K | – | 638 |
|
|
2021
Q1 | $366K | Sell |
31,700
-92,000
| -74% | -$1.06M | 0.08% | 303 |
|
|
2020
Q4 | $1.19M | Sell |
123,700
-7,600
| -6% | -$73.4K | 0.31% | 81 |
|
|
2020
Q3 | $1.18M | Buy |
131,300
+70,300
| +115% | +$633K | 0.29% | 85 |
|
|
2020
Q2 | $752K | Sell |
61,000
-90,200
| -60% | -$1.11M | 0.17% | 174 |
|
|
2020
Q1 | $1.36M | Buy |
+151,200
| New | +$1.36M | 0.29% | 76 |
|
|
2018
Q4 | – | Sell |
-53,100
| Closed | -$1.14M | – | 783 |
|
|
2018
Q3 | $1.14M | Buy |
+53,100
| New | +$1.14M | 0.19% | 149 |
|
|
2017
Q2 | – | Sell |
-14,000
| Closed | -$449K | – | 591 |
|
|
2017
Q1 | $449K | Buy |
+14,000
| New | +$449K | 0.21% | 185 |
|
|
2016
Q4 | – | Sell |
-24,655
| Closed | -$1.13M | – | 703 |
|
|
2016
Q3 | $1.13M | Buy |
24,655
+10,455
| +74% | +$481K | 0.74% | 15 |
|
|
2016
Q2 | $713K | Buy |
+14,200
| New | +$713K | 0.43% | 58 |
|